Skip to content

MDMA research published in 2022

122 studies whose primary subject is MDMA were published in 2022, up from 73 in 2021. Newest first. Back to the MDMA overview

Studies

MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder: The Devil Is in the Detail

December 27, 2022 James Phelps

A randomized trial of MDMA as an adjunct to psychotherapy for PTSD found it superior to placebo plus the same manualized therapy (effect size 0.9). However, the blinding in that study almost completely failed. Vocal public advocacy for psychedelics as adjuncts to psychotherapy is creating an environment of high positivity bias that is affecting research quality and results. Thus, a recent...

Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: A role of gut-microbiota-brain axis.

Psychiatry Research December 21, 2022 Youge Qu, Akifumi Eguchi, Xiayun Wan et al.

3,4-Methylenedioxymethamphetamine (MDMA), the most widely used illicit compound worldwide, is the most attractive therapeutic drug for post-traumatic stress disorder (PTSD). Recent observational studies of US adults demonstrated that lifetime MDMA use was associated with lower risk of depression. Here, we examined whether repeated administration of MDMA can affect resilience versus...

DOI: 10.1016/j.psychres.2022.115020 (opens in new tab) MDMA Brain Animals Mice, inbred c57bl +10

Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.

Scientific Reports December 19, 2022 Grant Jones, Diego Arias, Matthew K. Nock 18 citations

Suicide is one of the leading causes of death amongst adolescents and decades of research have failed to curb suicide rates within this population. There is thus a need to better understand factors that correlate with adolescent suicidal thoughts and behaviors (STBs). MDMA/ecstasy and classic psychedelics represent two areas for exploration, as use of these substances has been associated with...

Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines

Neuropharmacology December 15, 2022 David J Heal, Jane Gosden, Sharon L. Smith et al. 18 citations

Research on classical psychedelics (psilocybin, LSD and DMT) and entactogen, MDMA, has produced a renaissance in the search for more effective drugs to treat psychiatric, neurological and various peripheral disorders. Psychedelics and entactogens act though interaction with 5-HT2A and other serotonergic receptors and/or monoamine reuptake transporters. 5-HT, which serves as a neurotransmitter...

The economics of psychedelic-assisted therapies: A research agenda

Frontiers in Psychiatry December 5, 2022 Elliot Marseille, Stefano Bertozzi, James G. Kahn 51 citations

After a long hiatus, psychiatry is undergoing a resurgence of interest in psychedelic drugs as therapy for a wide range of mental health disorders Accumulating clinical evidence suggests substantial potential for psychedelics used in a therapeutic context, as treatment for, among other disorders, depression, post-traumatic stress disorder (PTSD), and addictions to tobacco, opioids and alcohol....

DOI: 10.3389/fpsyt.2022.1025726 (opens in new tab) MDMA Psilocybin Cost-effectiveness Health economics +5

Ecstasy metabolites and monoamine neurotransmitters upshift the Na+/K+ ATPase activity in mouse brain synaptosomes.

Archives of Toxicology December 2022 Daniel José Barbosa, João Paulo Capela, Luísa Maria Ferreira et al.

3,4-Methylenedioximethamphetamine (MDMA; "ecstasy") is a psychotropic drug with well-known neurotoxic effects mediated by hitherto not fully understood mechanisms. The Na+- and K+-activated adenosine 5'-triphosphatase (Na+/K+ ATPase), by maintaining the ion gradient across the cell membrane, regulates neuronal excitability. Thus, a perturbation of its function strongly impacts cell homeostasis,...

DOI: 10.1007/s00204-022-03370-7 (opens in new tab) Full text (opens in new tab) 3,4-Methylenedioxymethamphetamine MDMA MDMA Brain Effects MDMA Metabolites Monoamine neurotransmitters +2

Psicoterapia Assistida por MDMA: um Novo Paradigma no Tratamento da Perturbação de Stress Pós‐Traumático Resistente?

Revista Portuguesa de Psiquiatria e Saúde Mental November 27, 2022 Pedro Mota, Joana Proença Becker, Manuel João Quartilho

A perturbação de stress pós‐traumático (PSPT) é uma doença psiquiátrica comum, geralmente crónica, com severas implicações na qualidade de vida da pessoa afetada e da sua família, e que tem vindo a apresentar um crescente reconhecimento enquanto problema de Saúde Pública. Nas últimas duas décadas, estudos clínicos com 3,4‐metilenodioximetanfetamina (MDMA) têm vindo a demonstrar...

Evaluating the attitudes of mental health professionals towards trials of MDMA: a randomised vignette trial

BMJ Open November 26, 2022 Nick Glozier, Ben Colagiuri, Dean J Wright 3 citations

Objectives To compare attitudes of mental health (MH) professionals towards trials of methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP), with a neutrally labelled pharmacotherapy trial.Design A randomised controlled vignette study design, with experimenters blinded to group condition.Setting Participants were recruited online via professional societies.Participants Psychiatrists,...

Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012–2021

Drugs, Habits and Social Policy November 24, 2022 Ruben Q Vrolijk, Fiona Measham, Adrià Quesada et al.

Purpose The 3,4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has increased enormously throughout Europe across the past decade. This study aims to determine whether this is caused by the production of “stronger” tablets (more mg MDMA per mg of tablet), or if tablets have simply been getting larger and heavier (more mg of tablet in total). Design/methodology/approach A data set...

Šamanizem na Slovenskem? Dileme o pojmih in pojavih šamanizma, obsedenosti in ekstazeShamanism on Slovenian Territory? Dilemmas Concerning the Phenomena of Shamanism, Spirit Possession and Ecstasy

Studia Mythologica Slavica November 23, 2022 Zmago Šmitek 1 citation

Are there elements of shamanism in Slovenian folklore tradition, or is it more adequate to use terms like spirit possession or ecstasy? The author’s conclusion, which is based Slovenian data and on comparative literature, is that it is difficult to differentiate these terms in practice. He also explains the possible original meaning of the names kresnik and vedomec.

Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans

International Journal of Molecular Sciences November 23, 2022 Lourdes Poyatos, Alfredo Fabrizio Lo Faro, Diletta Berardinelli et al. 22 citations

The aim of this study is to define, for the first time, human methylone and HMMC plasma pharmacokinetics following controlled administration of 50–200 mg methylone to 12 male volunteers. A new LC-MS/MS method was validated to quantify methylone, MDMA, and their metabolites in plasma. The study was a randomized, cross-over, double-blinded and placebo-controlled study, with a total of 468 plasma...

Effects of 3,4-methylenedioxymethamphetamine and methamphetamine on motor vehicle driving performance: A systematic review of experimental and observational studies.

Journal of Forensic Sciences November 21, 2022 Ian R McGrane, Nathan C Ramsbacher, William C Rook et al.

Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA) are common drugs of abuse and driving under their influence may occur in 1 million people yearly in the United States. This systematic review fills the currently unmet need in understanding the effects of METH and MDMA on motor vehicle driving performance (MVP) and provides insight into the forensic community. A PubMed search...

DOI: 10.1111/1556-4029.15179 (opens in new tab) MDMA Humans N-methyl-3,4-methylenedioxyamphetamine Motor vehicles +5

Impact of fluoxetine preexposure on MDMA-induced taste avoidance in male and female rats.

Experimental and Clinical Psychopharmacology November 17, 2022 Sara K Bowman, Shihui Huang, Marissa E Vasquez et al.

The use of both prescription and illicit drugs creates the potential for drug interactions as a function of both pharmacokinetic and pharmacodynamic processes. One such interaction is that of fluoxetine and methylenedioxymethamphetamine (MDMA) in which fluoxetine attenuates the positive-like effects of MDMA. The present work extends the analysis of their interaction by examining the impact of...

DOI: 10.1037/pha0000610 (opens in new tab) Full text (opens in new tab) Animals Rats, sprague-dawley N-methyl-3,4-methylenedioxyamphetamine Fluoxetine +3

MDMA for the treatment of misophonia, a proposal.

Frontiers in Psychiatry November 10, 2022

Misophonia is a disorder characterized by negative physical and emotional reactions to certain trigger sounds, such as chewing food. Up to 50% of population samples endorse some symptoms of misophonia, with about 20% having symptoms that impair normal life functioning. Most misophonia patients exhibit intense negative emotions and autonomic arousal (the fight-flight-freeze response) in response...

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder

Frontiers in Psychiatry November 3, 2022 Devon Christie, Berra Yazar-Klosinski, Ekaterina Nosova et al. 8 citations

IntroductionIncreasing evidence demonstrates 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy (MDMA-AT) may be a safe and effective treatment for post-traumatic stress disorder (PTSD). There is growing interest in MDMA-AT to address a range of other health challenges. Chronic pain and PTSD are frequently comorbid, reciprocally interdependent conditions, though the possible role of...

Therapeutic setting as an essential component of psychedelic research methodology: Reporting recommendations emerging from clinical trials of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder

Frontiers in Psychiatry November 3, 2022 Lauren Okano, Bri Deyo, Alida Brandenburg et al. 24 citations

Research of psychedelic assisted therapies is at an all-time high, though few studies highlight extra-pharmacological factors that may affect treatment efficacy. One critical set of attributes includes the therapeutic setting itself, which describe the physical and socio-cultural environments in which the drug-assisted session occurs. Despite enduring consensus of the influence of setting,...

DOI: 10.3389/fpsyt.2022.965641 (opens in new tab) Traumatic stress Psychotherapist Clinical trial Clinical psychology

Assessing the quality of publicly available videos on MDMA‐assisted psychotherapy for PTSD

American Journal on Addictions November 1, 2022 Mariam Kyarunts, Meghna P. Mansukhani, Larissa L. Loukianova et al. 26 citations

AbstractBackground and ObjectivesPatients increasingly rely on the Internet for healthcare information. This study aimed to evaluate the quality of videos on 3,4‐methylenedioxymethamphetamine (MDMA)‐assisted psychotherapy for posttraumatic stress disorder (PTSD) on YouTube™.MethodsYouTube™ was searched for the terms “MDMA” and “PTSD.” The 100 most viewed videos were analyzed using three...

Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.

Pharmacology & Therapeutics November 1, 2022 Sanket B Raut, Padmaja A Marathe, Liza Van Eijk et al. 62 citations

Post-traumatic stress disorder (PTSD), characterized by abnormally persistent and distressing memories, is a chronic debilitating condition in need of new treatment options. Current treatment guidelines recommend psychotherapy as first line management with only two drugs, sertraline and paroxetine, approved by U.S. Food and Drug Administration (FDA) for treatment of PTSD. These drugs have...

Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations

Naunyn-Schmiedeberg's Archives of Pharmacology November 1, 2022 Joachim Neumann, Karyna Azatsian, Christian Höhm et al. 7 citations

Abstract The use of recreational drugs like ephedrine, norephedrine, 3,4-methylenedioxymethamphetamine (MDMA), and mescaline can lead to intoxication and, at worst, to death. One reason for a fatal course of intoxication with these drugs might lie in cardiac arrhythmias. To the best of our knowledge, their inotropic effects have not yet been studied in isolated human cardiac preparations....

Ignatius Loyola and Konstantin Stanislavsky in the interpretation of Sergey Eisenstein: from mystical ecstasy to editing

St. Tikhons' University Review October 31, 2022 Tinatin Do Egito

The article examines the point of Soviet art's 1920-1930 influence on secular processes in society. The model of the psychology of art proposed by L. Vygotsky, based on Marxist dogmatics, becomes the starting point for the search of creative elite, particularly, for the film director and art theorist Sergei Eisenstein. They are brought together by a common understanding of art as a sign system...